Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

In brief

This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.

Key facts

Study ID
NCT00160147
Run by
Solvay Pharmaceuticals
People needed
60
Starts
2005-12-01
Expected to finish
2008-01-01
Last updated by the study team
2015-02-09

Who can join

Age: 65 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.